whytestocks Monday, 11/18/19 08:45:30 PM Re: None Post # of 109423 News: $PMCB PharmaCyte Biotech Successfully Completes Final Manufacturing Run of Clinical Trial Product PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , announced today that its partner, Austrianova Singapore (Austrianova), has successful... In case you are interested PMCB - PharmaCyte Biotech Successfully Completes Final Manufacturing Run of Clinical Trial Product